Home - Products - Wnt/Notch/Hedgehog - Wnt/beta/catenin - Wnt/β-catenin agonist 2

Wnt/β-catenin agonist 2

CAS No. 943820-93-7

Wnt/β-catenin agonist 2( —— )

Catalog No. M35252 CAS No. 943820-93-7

Wnt/β-catenin agonist 2 activates Wnt/β-catenin signaling and is an effective Wnt agonist.

Purity : >98% (HPLC)

COA

Datasheet

HNMR

HPLC

MSDS

Handing Instructions

Size	Price / USD	Stock	Quantity
1 mL x 10 mM in DMSO	107	In Stock
5MG	112	In Stock
10MG	186	In Stock
25MG	317	In Stock
50MG	439	In Stock
100MG	625	In Stock
200MG	Get Quote	In Stock
500MG	1237	In Stock
1G	Get Quote	In Stock

Get Quotation Bulk Inquiry Add to Cart

Biological Information

Product Name

Wnt/β-catenin agonist 2
Note

Research use only, not for human use.
Brief Description

Wnt/β-catenin agonist 2 activates Wnt/β-catenin signaling and is an effective Wnt agonist.
Description

Wnt/β-catenin agonist 2 is a potent Wnt agonist. Wnt/β-catenin agonist 2 activates Wnt/β-catenin signaling and can be used in the research of diseases related to the signal transduction. (From patent WO2007078113A1, compound 39)
In Vitro

Wnt/β-catenin agonist 2 is a activator for β-Catenin in SW480 cell line. Wnt/β-catenin agonist 2 shows effect on differentiation ST2 Cell into osteoblasts.
In Vivo

——
Synonyms

——
Pathway

Wnt/Notch/Hedgehog
Target

Wnt/beta/catenin
Recptor

Wnt/beta-catenin | GSK-3
Research Area

——
Indication

——

Chemical Information

CAS Number

943820-93-7
Formula Weight

272.26
Molecular Formula

C13H12N4O3
Purity

>98% (HPLC)
Solubility

In Vitro:?DMSO : 50 mg/mL (183.65 mM; Ultrasonic )
SMILES

O=C(NCCn1cccn1)c1cc(on1)-c1ccco1
Chemical Name

——

Shipping & Storage Information

Storage

(-20℃)
Shipping

With Ice Pack
Stability

≥ 2 years

Reference

1. Jeong Woo Cho, et al. Isoxazole derivatives and use thereof. WO2007078113A1.

Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog

related products

Wnt pathway activato...

Wnt pathway activator 2, with an IC50 of 13 nM, is a potent Wnt activator.
EMT inhibitor-1

EMT inhibitor -1 is an inhibitor of Hippo, Wnt signaling and TGF- macrophages (TGF-) with antitumor activity.
Vantictumab

Vantictumab (OMP-18R5) is a humanized anti-FZD1/2/5/7/8 monoclonal antibody that inhibits Wnt pathway signaling and is used in research studies for the treatment of metastatic HER2-negative breast cancer and metastatic pancreatic adenocarcinoma.

Sign In Join Free